Sinostar PEC Holdings Limited (SGX:C9Q)

Market Cap	141.12M
Revenue (ttm)	981.06M
Net Income (ttm)	27.90M
Shares Out	960.00M
EPS (ttm)	0.04
PE Ratio	3.79
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54,400
Average Volume	26,495
Open	0.1470
Previous Close	0.1470
Day's Range	0.1470 - 0.1470
52-Week Range	0.1100 - 0.1740
Beta	0.51
RSI	48.98
Earnings Date	Aug 13, 2025

About Theseus Pharmaceuticals

Sinostar PEC Holdings Limited, an investment holding company, produces and supplies petrochemical products in the People’s Republic of China. It operates in two segments, Gas Separation, and Transport and Logistic Services. The company offers propylene, polypropylene, purified isobutylene, methyl tert-butyl ether, hydrogen, mixed gas, and processed liquefied petroleum gas (LPG) products. It also provides logistics and transportation services for delivering liquefied petroleum gas and petrochemical related products. The company was incorporated ...

• Industry: Petroleum Refining
• Founded: 2006
• Employees: 677
• Stock Exchange: Singapore Exchange
• Ticker Symbol: C9Q

Financial Performance

In 2024, Sinostar PEC Holdings's revenue was 5.46 billion, an increase of 2.34% compared to the previous year's 5.33 billion. Earnings were 170.07 million, a decrease of -21.85%.